The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2008
Filed:
Aug. 25, 2005
Michael R Hale, Bedford, MA (US);
Clarence W Andrews, Iii, Durham, NC (US);
Eric S Furfine, Durham, NC (US);
Ronald G Sherrill, Cary, NC (US);
Andrew Spaltenstein, Raleigh, NC (US);
Gregory T Lowen, Williamsburg, VA (US);
Michael R Hale, Bedford, MA (US);
Clarence W Andrews, III, Durham, NC (US);
Eric S Furfine, Durham, NC (US);
Ronald G Sherrill, Cary, NC (US);
Andrew Spaltenstein, Raleigh, NC (US);
Gregory T Lowen, Williamsburg, VA (US);
Vertex Pharmaceuticals Incorporated, Cambridge, MA (US);
Abstract
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods For inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.